1Visser H,Ie Cessie S,Vos K,et al.How to diagnose rheumatoid arthritis early:a prediction model for persistent(erosive)arthritis(J).Arthritis Rheum,2002;46(2):357-65.
2Schellekens GA,Visser H,de Jong BA,et al.The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide(J).Arthritis Rheum,2000;43(1):155-63.
3Matsui T,Shimada K,Ozawa N,et al.Diagnostic utility of anti-cyclic cit-rullinated peptide antibodies for very early rheumatoid arthritis(J).J Rheumatol,2006;33:2390-7.
6Kroot EJ,De Jong BA,Vanleeuwen MA,et al.The prognostic value of an-ti-cyclic citrullinated peptide antibody inpatients with recent-onset rheu-matoid arthritis(J).Arthritis Rheum,2000;43(10):1831-5.
8Aleninus G,Berglin E,Rantapaa Dahlgvist S.Antibodies against cyclic citrullinated peptide(CCP)in patients with psoriasis with or without in-flammatory joint manifestations(J).Anna Rheum Dis,2005;64(suppl3):1080.
4Schellekens GA, Visser H, de jang BAW, et al. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide [J]. Arthritis Rheum,2000,43:155.
5Bizzaro N, Mazzanti G, Tonutti E, et al. Diagnostic accuracy of the anticitndline antibody assay for rheumatoid arthritis[J]. Clinical Chemistry, 2001,47(61) : 1089.
6Amett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 criteria for the classification of rheumatoid arthritis[J]. Arthritis Rheum, 1988,31:315.
7Papadopoulos NG, Tsiaousis GZ, Pavlitou-Tsiontsi A, et al. Does the Presence of Anti-CCP Autoantibodies and Their Serum Levels Influence the Severity and Activity in Rheumatoid Arthritis Patients[J]. Clin Rev Allergy Immunol,2008,34(1) : 11.
8Samanci N,Ozdem S,Akbas H,et al. Diagnostic value and clinical significance of anti-CCP in patients with advanced rheumatoid arthritis[J]. J Natl Med Assoc,2005,97(8) : 1120.
9del Val del Amo N, Ibanez Bosch R, Fito Manteca C, et at. Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness[J] .Clin Exp Rheumatol,2006,24(3):281.
10Berglin E,Johansson T,Sundin U,et al. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset [J]. Ann Rheum Dis,2006,65(4) :453.
7Van Venrooij WJ,Hazes JM,Visser H.Anticitrullinated protein/pepfide an-tibody and its role in the diagnosis and prognosis of early rheumatoid arthritis[J].Neth J Med,2002,60:383-388.
8Amett FC,Edworthy SM,Bloch DA,et al.The American Rheumatism As- sociation 1987 revised criteria for the classification of rheumatoid arthritis [J].Arthrifis & Rheumatism,1988,31 (3):315.
9Visser H,le Cessie S,Vos K,et al.How to diagnose y:a prediction model for persistent(erosive)arthrit[J].Arthrifis Rheum,2002,46 (2):357-365.
10Schellekens GA,Visser H,de Jong BA, et al.The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citruUinated peptide [J].Arthritis Rheum,2000,431:155 - 163.
